Ticker

Analyst Price Targets — MIDD

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
February 24, 2026 12:00 pmCanaccord Genuity$187.00$158.15TheFly Middleby price target raised to $187 from $175 at Canaccord
December 10, 2025 10:34 amSaree BoroditskyJefferies$175.00$129.00TheFly Middleby upgraded to Buy from Hold at Jefferies
November 11, 2025 10:31 amBarclays$168.00$123.16TheFly Middleby price target lowered to $168 from $180 at Barclays
October 20, 2025 10:57 amMircea DobreBarclays$180.00$133.39TheFly Middleby price target raised to $180 from $165 at Barclays
September 4, 2025 9:54 amChris SenyekWolfe Research$163.00$135.64TheFly Middleby initiated with an Outperform at Wolfe Research
September 2, 2025 10:39 amCanaccord Genuity$175.00$137.37TheFly Middleby price target raised to $175 from $162 at Canaccord
August 4, 2025 1:19 pmSeaport Global$167.00$141.81TheFly Middleby price target lowered to $167 from $205 at Seaport Research
August 27, 2024 9:07 amJeffrey HammondKeyBanc$160.00$140.59StreetInsider KeyBanc Reiterates Overweight Rating on Middleby Corp (MIDD)
June 5, 2024 6:27 amSaree BoroditskyJefferies$170.00$127.01StreetInsider Jefferies Reiterates Buy Rating on Middleby Corp (MIDD)
May 9, 2024 6:45 amBrian McNamaraCanaccord Genuity$159.00$138.58StreetInsider Middleby Corp (MIDD) PT Lowered to $159 at Canaccord Genuity

Latest News for MIDD

Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced a high-impact panel discussion, “From Debate to Deployment: Responsible, Practical AI in MIDD,” to be held during the upcoming American Society for Clinical Pharmacology &…

Business Wire • Mar 3, 2026
Cary Street Partners Financial LLC Takes Position in The Middleby Corporation $MIDD

Cary Street Partners Financial LLC bought a new position in shares of The Middleby Corporation (NASDAQ: MIDD) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 5,105 shares of the industrial products company's stock, valued at approximately $679,000. A number of other

Defense World • Mar 1, 2026
Middleby (MIDD) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Middleby (MIDD) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research • Feb 26, 2026
Middleby (MIDD) Beats Q4 Earnings Estimates

Middleby (MIDD) came out with quarterly earnings of $2.42 per share, beating the Zacks Consensus Estimate of $2.27 per share. This compares to earnings of $2.88 per share a year ago.

Zacks Investment Research • Feb 26, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for MIDD.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top